Tin tức & Cập nhật

Chỉ hiển thị Multimedia

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

06 Feb 2021 bởi

Researchers from the Chinese University of Hong Kong (CUHK) have developed a novel peptide inhibitor that can reduce the accumulation of α-synuclein amyloid fibrils, slowing down the progress of deterioration in patients with Parkinson’s disease and other types of neurodegenerative diseases.

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

06 Feb 2021

Staying active protects against anxiety, apathy in Parkinson’s disease

05 Feb 2021 bởi

Higher levels of physical activity may help combat anxiety and apathy among patients with early Parkinson’s disease (PD), according to a recent Singapore study.

Staying active protects against anxiety, apathy in Parkinson’s disease

05 Feb 2021

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

05 Feb 2021 bởi

Bayer reveals major transformation in its pharmaceutical business with the use of breakthrough innovations aimed at helping patients with difficult-to-treat conditions.

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

05 Feb 2021

Tin tức & Cập nhật

Xem bài viết Thần kinh

Xem

Chuyên ngành:

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

Staying active protects against anxiety, apathy in Parkinson’s disease

Staying active protects against anxiety, apathy in Parkinson’s disease

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions